Flerlage, J. E., Birz, S., Castellino, S. M., Appel, B., Furner, B., Graglia, L., Henderson, T. O., Hodgson, D., Hoppe, B. S., Kahn, J., Keller, F. G., Kessel, S., Li, C., Li, M., Lucas, J., Mccarten, K., Metzger, M., Milgrom, S., Parsons, S. K., … Kelly, K. M. (2022). P086: Advancing Pediatric Hodgkin Lymphoma Research Through NODAL. HemaSphere, 6, 39–40. https://doi.org/10.1097/01.hs9.0000890912.56229.80

Jain, N. G., Ahram, D. F., Marasa, M., Rehman, A. U., May, H. J., Zacharoulis, S., Revah-Politi, A., Florido, M. E., Whittemore, G. B., Aggarwal, V. S., Hargus, G., Anyane-Yeboa, K., D’Agati, V. D., Lin, F., Jobanputra, V., & Sanna-Cherchi, S. (2022). Clinical Real-Time Genome Sequencing to Solve the Complex and Confounded Presentation of a Child With Focal Segmental Glomerulosclerosis and Multiple Malignancies. Kidney International Reports, 7(10), 2312–2316. https://doi.org/10.1016/j.ekir.2022.07.174

Mahajan, R. G., Moisander Joyce, H., Green, N., Hijiya, N., & Jain, N. G. (2022). Rare Presentation of Atypical Hemolytic Uremic Syndrome in a Child With Acute Lymphocytic Leukemia and Pancreatitis. Journal of Pediatric Hematology/Oncology, 44(7), 412–414. https://doi.org/10.1097/mph.0000000000002409

Pemmaraju, N., Cuglievan, B., Lasky, J., Kheradpour, A., Hijiya, N., Stein, A. S., Meshinchi, S., Mullen, C., Angelucci, E., Vinti, L., Mughal, T. I., & Pawlowska, A. (2022). AML-392 Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm in Pediatric Patients With Tagraxofusp, a CD123-Targeted Therapy. Clinical Lymphoma Myeloma and Leukemia, 22, S244–S245. https://doi.org/10.1016/s2152-2650(22)01284-8

Askew, M. A., Smaldone, A. M., Gold, M. A., Smith‐Whitley, K., Strouse, J. J., Jin, Z., & Green, N. S. (2022). Pediatric hematology providers’ contraceptive practices for female adolescents and young adults with sickle cell disease: A national survey. Pediatric Blood & Cancer, 69(10). Portico. https://doi.org/10.1002/pbc.29877

Ford, M., Mauro, M., Aftandilian, C., Sakamoto, K. M., & Hijiya, N. (2022). Management of Chronic Myeloid Leukemia in Children and Young Adults. Current Hematologic Malignancy Reports, 17(5), 121–126. https://doi.org/10.1007/s11899-022-00673-5

Li, Y., Goldberg, E. M., Chen, X., Xu, X., McGuire, J. T., Leuzzi, G., Karagiannis, D., Tate, T., Farhangdoost, N., Horth, C., Dai, E., Li, Z., Zhang, Z., Izar, B., Que, J., Ciccia, A., Majewski, J., Yoon, A. J., Ailles, L., … Lu, C. (2022). Histone methylation antagonism drives tumor immune evasion in squamous cell carcinomas. Molecular Cell, 82(20), 3901-3918.e7. https://doi.org/10.1016/j.molcel.2022.09.007

Lee, M. T., & Ogu, U. O. (2022). Sickle cell disease in the new era: advances in drug treatment. Transfusion and Apheresis Science, 61(5), 103555. https://doi.org/10.1016/j.transci.2022.103555

Ford, M., Jin, Z., Orlando, E., Lipsky, A., Sawas, A., Pro, B., & Amengual, J. (2022). ABCL-542 Prevalence and Characterization of EBV-Negative Post-Transplant Lymphoproliferative Disorder. Clinical Lymphoma Myeloma and Leukemia, 22, S382–S383. https://doi.org/10.1016/s2152-2650(22)01546-4

Lewis, J., Greenway, S. C., Khan, F., Singh, G., Bhatia, M., & Guilcher, G. M. T. (2022). Assessment of donor cell engraftment after hematopoietic stem cell transplantation for sickle cell disease: A review of current and future methods. American Journal of Hematology, 97(10), 1359–1371. Portico. https://doi.org/10.1002/ajh.26599

Green, N. S., Manwani, D., Smith‐Whitley, K., Aygun, B., Appiah‐Kubi, A., & Smaldone, A. M. (2022). Mental health assessment of youth with sickle cell disease and their primary caregivers during the COVID‐19 pandemic. Pediatric Blood & Cancer, 69(9). Portico. https://doi.org/10.1002/pbc.29797

He, R., & Zhang, Z. (2022). Rad53 arrests leading and lagging strand DNA synthesis via distinct mechanisms in response to DNA replication stress. BioEssays, 44(9). Portico. https://doi.org/10.1002/bies.202200061

Zhang, H., Lin, X., & Zha, S. (2022). Revisiting PARP2 and PARP1 trapping through quantitative live-cell imaging. Biochemical Society Transactions, 50(4), 1169–1177. https://doi.org/10.1042/bst20220366

Kahn, J. M., Zhang, X., Kahn, A. R., Castellino, S. M., Neugut, A. I., Schymura, M. J., Boscoe, F. P., & Keegan, T. H. M. (2022). Racial Disparities in Children, Adolescents, and Young Adults with Hodgkin Lymphoma Enrolled in the New York State Medicaid Program. Journal of Adolescent and Young Adult Oncology, 11(4), 360–369. https://doi.org/10.1089/jayao.2021.0131

Afungchwi, G. M., Kruger, M., Hesseling, P., van Elsland, S., Ladas, E. J., & Marjerrison, S. (2022). Survey of the use of traditional and complementary medicine among children with cancer at three hospitals in Cameroon. Pediatric Blood & Cancer, 69(8). Portico. https://doi.org/10.1002/pbc.29675

Moskop, A., Pommert, L., Baggott, C., Prabhu, S., Pacenta, H. L., Phillips, C. L., Rossoff, J., Stefanski, H. E., Talano, J.-A., Margossian, S. P., Verneris, M. R., Myers, G. D., Karras, N. A., Brown, P. A., Qayed, M., Hermiston, M. L., Satwani, P., Krupski, C., Keating, A. K., … Schultz, L. M. (2022). Real-world use of tisagenlecleucel in infant acute lymphoblastic leukemia. Blood Advances, 6(14), 4251–4255. https://doi.org/10.1182/bloodadvances.2021006393

Beauchemin, M. P., Raghunathan, R. R., Accordino, M. K., Cogan, J. C., Kahn, J. M., Wright, J. D., & Hershman, D. L. (2022). New persistent opioid use among adolescents and young adults with sarcoma. Cancer, 128(14), 2777–2785. Portico. https://doi.org/10.1002/cncr.34238

Rubens, J. A., Erker, C., Lindsay, H., Ho, B., Li, B., Bouffet, E., Cohen, A., Eberhart, C., Ertl-Wagner, B., Mahajan, A., Zacharoulis, S., Huang, A., & Packer, R. (2022). Infantile suprasellar tumor diagnosed as a pineoblastoma RB1 subgroup and treatment challenges: A pediatric SNO Molecular Tumor Board. Neuro-Oncology Advances, 4(1). https://doi.org/10.1093/noajnl/vdac092

Fernández, E. C., Wang, J., Griffin, A., Minns, H., Wei, H.-J., Zhang, X., Szalontay, L., Mundi, P., Wu, C.-C., Gartrell, R., Zacharoulis, S., Califano, A., & Pavisic, J. (2022). DIPG-57. A systems biology approach to defining and targeting master regulator dependencies from bulk and single-Cell RNA-seq in diffuse midline glioma (DMG). Neuro-Oncology, 24(Supplement_1), i31–i32. https://doi.org/10.1093/neuonc/noac079.114

McQuillan, N., Tazhibi, M., Wei, H.-J., Pouliopoulos, A., Bendau, E., Carrion, A. W., Berg, A., Kokossis, D., Zhang, X., Zhang, Z., Englander, Z., Yoh, N., Jan, C.-I., Gartrell, R. D., Garvin, J., Szalontay, L., Konofagou, E., Zacharoulis, S., & Wu, C.-C. (2022). MODL-25. Radiation and focused ultrasound–mediated blood–brain barrier opening for DMG: safety and feasibility of combinatorial therapy. Neuro-Oncology, 24(Supplement_1), i174–i174. https://doi.org/10.1093/neuonc/noac079.648

Pemmaraju, N., Cuglievan, B., Lasky, J., Kheradpour, A., Hijiya, N., Stein, A. S., Meshinchi, S., Mullen, C., Angelucci, E., Vinti, L., Mughal, T. I., & Pawlowska, A. (2022). P521: TREATMENT OF BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM IN PEDIATRIC PATIENTS WITH TAGRAXOFUSP, A CD123-TARGETED THERAPY. HemaSphere, 6, 420–421. https://doi.org/10.1097/01.hs9.0000844972.31512.dd

Webster Carrion, A., Wei, H.-J., McQuillan, N., Tazhibi, M., Kokossis, D., Berg, X., Minns, H., Zhang, X., Zhang, Z., Wang, J., Fernandez, E. C., Jan, C.-I., Padilla, O., Gartrell, R. D., Becher, O., Jr, J. H. G., Pavisic, J., Szalontay, L., Konofagou, E. E., … Wu, C.-C. (2022). MODL-24. Focused ultrasound-mediated blood-brain barrier opening and panobinostat in a thalamic syngeneic murine DMG model is feasible and safe. Neuro-Oncology, 24(Supplement_1), i174–i174. https://doi.org/10.1093/neuonc/noac079.647

Minns, H. E., Padilla, O., Wei, H.-J., Webster-Carrion, A., Tazhibi, M., McQuillan, N., Zhang, X., Yeh, R., Zhang, Z., Szalontay, L., Pavisic, J., Garty, G., Garvin, J., Zacharoulis, S., Canoll, P., Vanpouille-Box, C. I., Menon, V., Olah, M., Rabadan, R., … Gartrell, R. D. (2022). DIPG-45. Radiation induces a robust interferon response in Diffuse Midline Glioma (DMG), improving the potential for combination immunotherapy. Neuro-Oncology, 24(Supplement_1), i28–i29. https://doi.org/10.1093/neuonc/noac079.102

Zacharoulis, S., Szalontay, L., CreveCoeur, T., Neira, J., Higgins, D., Englander, Z., Spinazzi, E., Sethi, C., Canoll, P., Garvin, J., Zylber, R., Damment, S., Zamoryakhin, D., Maddocks, A., Feldstein, N., & Bruce, J. (2022). DDEL-07. A Phase I study examining the feasibility of intermittent convection-enhanced delivery (CED) of MTX110 for the treatment of children with newly diagnosed diffuse midline gliomas (DMGs). Neuro-Oncology, 24(Supplement_1), i35–i35. https://doi.org/10.1093/neuonc/noac079.128

Genecin, I., Fullwood, D., Moisander-Joyce, H., Padilla, O., Minns, H., Garvin, J., Szalontay, L., Wu, C.-C., Kahn, J., & Gartrell, R. D. (2022). EPID-07. Outcome disparities in children, adolescents and young adults with medulloblastoma: A population-based analysis. Neuro-Oncology, 24(Supplement_1), i48–i48. https://doi.org/10.1093/neuonc/noac079.175

Hillier, K., Rothman, J. A., Klaassen, R. J., Neunert, C., Rose, M. J., Grace, R. F., & Lambert, M. P. (2022). SARS‐CoV‐2 vaccination in pediatric patients with immune thrombocytopenia. Pediatric Blood & Cancer, 69(7). Portico. https://doi.org/10.1002/pbc.29760

Serra-Cardona, A., Duan, S., Yu, C., & Zhang, Z. (2022). H3K4me3 recognition by the COMPASS complex facilitates the restoration of this histone mark following DNA replication. Science Advances, 8(18). https://doi.org/10.1126/sciadv.abm6246

Orjuela-Grimm, M., Marti-Castaner, M., Bhatt-Carreño, S., Castro, M. A., Restrepo Henao, A., Pinilla, H., Rodriguez, D., Ruiz, A., Valentin, M., Levine, A. R., Gonzalez, R., Zuleta, M., Pharel, M., Medina, P., & Lewis-Fernandez, R. (2022). Household composition after resettlement and emotional health in adolescent migrants. Journal of Migration and Health, 5, 100103. https://doi.org/10.1016/j.jmh.2022.100103

Kang, T. Z. E., Wan, Y. C. E., Zhang, Z., & Chan, K. M. (2022). Lrwd1 impacts cell proliferation and the silencing of repetitive DNA elements. Genesis, 60(4–5). Portico. https://doi.org/10.1002/dvg.23475

Fernández, C. R., Licursi, M., Wolf, R., Lee, M. T., & Green, N. S. (2021). Food insecurity, housing instability, and dietary quality among children with sickle cell disease: Assessment from a single urban center. Pediatric Blood & Cancer, 69(5). Portico. https://doi.org/10.1002/pbc.29463

Lin, X., Jiang, W., Rudolph, J., Lee, B. J., Luger, K., & Zha, S. (2022). PARP inhibitors trap PARP2 and alter the mode of recruitment of PARP2 at DNA damage sites. Nucleic Acids Research, 50(7), 3958–3973. https://doi.org/10.1093/nar/gkac188

Fabrizio, V. A., Boelens, J. J., Mauguen, A., Baggott, C., Prabhu, S., Egeler, E., Mavroukakis, S., Pacenta, H., Phillips, C. L., Rossoff, J., Stefanski, H. E., Talano, J.-A., Moskop, A., Margossian, S. P., Verneris, M. R., Myers, G. D., Karras, N. A., Brown, P. A., Qayed, M., … Curran, K. J. (2022). Optimal fludarabine lymphodepletion is associated with improved outcomes after CAR T-cell therapy. Blood Advances, 6(7), 1961–1968. https://doi.org/10.1182/bloodadvances.2021006418

Kwarteng-Siaw, M., Benneh-Akwasi Kuma, A., & Green, N. S. (2021). Transition Preparation and Satisfaction of Care Among Adolescents and Young Adults With Sickle Cell Disease at the Ghana Institute of Clinical Genetics. Journal of Pediatric Hematology/Oncology, 44(3), e682–e688. https://doi.org/10.1097/mph.0000000000002316

Nauman, G., Danzl, N. M., Lee, J., Borsotti, C., Madley, R., Fu, J., Hölzl, M. A., Dahmani, A., Dorronsoro Gonzalez, A., Chavez, É., Campbell, S. R., Yang, S., Satwani, P., Liu, K., & Sykes, M. (2022). Defects in Long-Term APC Repopulation Ability of Adult Human Bone Marrow Hematopoietic Stem Cells (HSCs) Compared with Fetal Liver HSCs. The Journal of Immunology, 208(7), 1652–1663. https://doi.org/10.4049/jimmunol.2100966

Laurie, K. L., Lee, P., Rademaker, A., Alonzo, T. A., Wang, Y., Powell, B. L., Wu, D., Larson, R., Kutny, M., Gregory, J., Hijiya, N., & Feusner, J. (2022). Obesity in children with acute promyelocytic leukemia: What is its prevalence and prognostic significance? Pediatric Blood & Cancer, 69(6). Portico. https://doi.org/10.1002/pbc.29613

Schultz, L. M., Baggott, C., Prabhu, S., Pacenta, H. L., Phillips, C. L., Rossoff, J., Stefanski, H. E., Talano, J.-A., Moskop, A., Margossian, S. P., Verneris, M. R., Myers, G. D., Karras, N. A., Brown, P. A., Qayed, M., Hermiston, M., Satwani, P., Krupski, C., Keating, A. K., … Laetsch, T. W. (2022). Disease Burden Affects Outcomes in Pediatric and Young Adult B-Cell Lymphoblastic Leukemia After Commercial Tisagenlecleucel: A Pediatric Real-World Chimeric Antigen Receptor Consortium Report. Journal of Clinical Oncology, 40(9), 945–955. https://doi.org/10.1200/jco.20.03585

Ladas, E. J. (2022). 3.25 Diet in Children with Malignant Disease. Pediatric Nutrition in Practice, 394–402. https://doi.org/10.1159/000518095

Wontakal, S. N., Britto, M., Zhang, H., Han, Y., Gao, C., Tannenbaum, S., Durham, B. H., Lee, M. T., An, X., & Mishima, M. (2022). RACGAP1 variants in a sporadic case of CDA III implicate the dysfunction of centralspindlin as the basis of the disease. Blood, 139(9), 1413–1418. https://doi.org/10.1182/blood.2021012334

Rogers, J. R., Pavisic, J., Ta, C. N., Liu, C., Soroush, A., Kuen Cheung, Y., Hripcsak, G., & Weng, C. (2022). Leveraging electronic health record data for clinical trial planning by assessing eligibility criteria’s impact on patient count and safety. Journal of Biomedical Informatics, 127, 104032. https://doi.org/10.1016/j.jbi.2022.104032

Evrin, C., Serra‐Cardona, A., Duan, S., Mukherjee, P. P., Zhang, Z., & Labib, K. P. M. (2022). Spt5 histone binding activity preserves chromatin during transcription by RNA polymerase II. The EMBO Journal, 41(5). Portico. https://doi.org/10.15252/embj.2021109783

Avutu, V., Monga, V., Mittal, N., Saha, A., Andolina, J. R., Bell, D. E., Fair, D. B., Flerlage, J. E., Frediani, J. N., Heath, J. L., Kahn, J. M., Reichek, J. L., Super, L., Terao, M. A., Freyer, D. R., & Roth, M. E. (2022). Use of Communication Technology to Improve Clinical Trial Participation in Adolescents and Young Adults With Cancer: Consensus Statement From the Children’s Oncology Group Adolescent and Young Adult Responsible Investigator Network. JCO Oncology Practice, 18(3), 224–231. https://doi.org/10.1200/op.21.00554

Moerdler, S., Steinberg, D. M., Jin, Z., Cole, P. D., Kesselheim, J., Levy, A. S., Roth, M., & Rosenthal, S. L. (2021). Provider and staff crisis well‐being associated with trust in leadership and baseline burnout. Pediatric Blood & Cancer, 69(3). Portico. https://doi.org/10.1002/pbc.29497

Tran, T. H., Langlois, S., Meloche, C., Caron, M., Saint-Onge, P., Rouette, A., Bataille, A. R., Jimenez-Cortes, C., Sontag, T., Bittencourt, H., Laverdière, C., Lavallée, V.-P., Leclerc, J.-M., Cole, P. D., Gennarini, L. M., Kahn, J. M., Kelly, K. M., Michon, B., Santiago, R., … Sinnett, D. (2022). Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001. Blood Advances, 6(4), 1329–1341. https://doi.org/10.1182/bloodadvances.2021005634

Troy, C., Gill, B. J. A., Miller, M. L., Hickman, R. A., Canoll, P., Zacharoulis, S., Feldstein, N. A., & Bruce, J. N. (2022). Adenocarcinoma Arising in a Yolk Sac Tumor of the Pineal Gland. Journal of Neuropathology & Experimental Neurology, 81(4), 291–295. https://doi.org/10.1093/jnen/nlac002

Menolfi, D., & Zha, S. (2021). Targeting BRCA-mutated tumors in mitosis. Nature Cancer, 2(12), 1296–1297. https://doi.org/10.1038/s43018-021-00293-7

Fabrizio, V. A., Phillips, C. L., Lane, A., Baggott, C., Prabhu, S., Egeler, E., Mavroukakis, S., Pacenta, H., Rossoff, J., Stefanski, H. E., Talano, J.-A., Moskop, A., Margossian, S. P., Verneris, M. R., Myers, G. D., Karras, N. A., Brown, P. A., Qayed, M., Hermiston, M., … Schultz, L. M. (2022). Tisagenlecleucel outcomes in relapsed/refractory extramedullary ALL: a Pediatric Real World CAR Consortium Report. Blood Advances, 6(2), 600–610. https://doi.org/10.1182/bloodadvances.2021005564

Schneider, N. M., Steinberg, D. M., Pahl, D. A., Steffin, D. H. M., & Gangopadhyay, M. (2023). Ethical Quandaries at End of Life: Navigating Real-World Case Examples as a Pediatric Psychologist. Clinical Practice in Pediatric Psychology, 11(2), 244–251. https://doi.org/10.1037/cpp0000432

Das, A., Sudhaman, S., Morgenstern, D., Coblentz, A., Chung, J., Stone, S. C., Alsafwani, N., Liu, Z. A., Karsaneh, O. A. A., Soleimani, S., Ladany, H., Chen, D., Zatzman, M., Cabric, V., Nobre, L., Bianchi, V., Edwards, M., Sambira Nahum, L. C., Ercan, A. B., … Tabori, U. (2022). Genomic predictors of response to PD-1 inhibition in children with germline DNA replication repair deficiency. Nature Medicine, 28(1), 125–135. https://doi.org/10.1038/s41591-021-01581-6

Rodriguez-Hernandez, A., & Kahn, J. M. (2022). Improving Health Equity and Reducing Pediatric Cancer Disparities: The Role of the Medical Home. Pediatric Annals, 51(1). https://doi.org/10.3928/19382359-20211207-02

Beauchemin, M., Marshall, A. F., Ricci, A. M., Lopez, I. D., Yao, Y., Lee, A., Jin, Z., & Sulis, M. L. (2021). Bacteremia in Febrile, Non-neutropenic, and Well-appearing Children With Cancer. Journal of Pediatric Hematology/Oncology, 44(1), e194–e198. https://doi.org/10.1097/mph.0000000000002201